Resmed Corp
Pharmaceutical & medical device company payment data from CMS Open Payments.
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $2.4M | 155 | 64.7% |
| Consulting Fee | $568,430 | 141 | 15.5% |
| Entertainment | $170,116 | 112 | 4.6% |
| Food and Beverage | $148,448 | 5,947 | 4.0% |
| Gift | $136,730 | 359 | 3.7% |
| Education | $102,999 | 632 | 2.8% |
| Royalty or License | $87,428 | 10 | 2.4% |
| Grant | $52,350 | 4 | 1.4% |
| Charitable Contribution | $19,825 | 10 | 0.5% |
| Honoraria | $3,650 | 15 | 0.1% |
| Space rental or facility fees (teaching hospital only) | $3,530 | 5 | 0.1% |
| Travel and Lodging | $2,364 | 10 | 0.1% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| DPAP | $378,000 | 0 | 1 |
| ApneaLink Air Validation | $300,542 | 1 | 11 |
| Impact of a Novel Sleep Apnea Management Group Intervention on Positive Airway Pressure Adherence | $158,468 | 0 | 2 |
| Partners IIR | $157,471 | 0 | 2 |
| Astral iVAPS AutoEPAP | $155,129 | 3 | 4 |
| P2P Insomnia Trial | $139,197 | 1 | 11 |
| HOP-HF | $96,250 | 1 | 2 |
| HOP-COPD | $96,250 | 1 | 1 |
| CAT-PEF | $95,924 | 4 | 9 |
| medXcloud | $95,490 | 1 | 7 |
| Study of R289 in Participants With Lower-risk Myelodysplastic Syndromes (LR MDS) | $81,237 | 0 | 4 |
| Fostamatinib (FOS) | $67,484 | 0 | 4 |
| CAT-HF | $51,554 | 5 | 10 |
| ASAP-HF | $47,705 | 1 | 2 |
| PEP-ASV | $41,750 | 0 | 1 |
| CMS Health Econ Analysis | $41,600 | 0 | 1 |
| A Validation Study of the NightOwl Home Sleep Apnea Test | $41,400 | 0 | 4 |
| Upenn Registry | $38,000 | 0 | 3 |
| MFMU SLEEP Clinical Trial (A RCT if CPAP for sleep apnea in pregnancy) | $37,700 | 0 | 1 |
| U Penn Registry | $34,800 | 1 | 1 |
| P2P Insomnia | $30,567 | 1 | 4 |
| Sleep Reading and CPAP Monitoring Center for MFMU SLEEP Trial | $29,362 | 0 | 2 |
| Engineering validation of Leo device to assess clinical control of children recovering from acute asthma exacerbation | $27,531 | 0 | 1 |
| HOT-HMV | $25,000 | 2 | 2 |
| PEP ASV | $21,500 | 0 | 1 |
| A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia | $20,990 | 0 | 5 |
| Hospital to Home NIV | $11,803 | 0 | 2 |
| IIR-VA Hospital to Home NIV | $10,680 | 0 | 1 |
| Hospital to Home Pilot: Preventing Readmissions with Non-Invasive Ventilation following Acute Exacerbations of Chronic Obstructive Pulmonary Disease | $9,215 | 0 | 1 |
| Pediatric ApneaLink Air Validation | $3,380 | 0 | 1 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Unknown Provider | — | — | $254,997 | $0 |
| Dr. Sunil Sharma, M.d, M.D | Internal Medicine | Philadelphia, PA | $240,357 | $0 |
| Dr. Barry Krakow, Md, MD | Sleep Medicine | Savannah, GA | $207,138 | $0 |
| Dr. Atul Malhotra, Md, MD | Critical Care Medicine | San Diego, CA | $76,011 | $0 |
| Dr. Richard Berry, Md, MD | Pulmonary Disease | Gainesville, FL | $73,210 | $0 |
| Dr. Anthony Demaria, M.d, M.D | Cardiovascular Disease | San Diego, CA | $70,000 | $0 |
| Sheila Tsai, Md, MD | Sleep Medicine | Denver, CO | $67,226 | $0 |
| Emerson Wickwire, Ph.d, PH.D | Sleep Medicine | Baltimore, MD | $55,180 | $0 |
| Lisa Wolfe, Md, MD | Pulmonary Disease | Chicago, IL | $49,808 | $0 |
| Jagdeep Bijwadia, Md, Fccp, Dabsm, MD, FCCP, DABSM | Sleep Medicine | Rochester, MN | $45,515 | $0 |
| Krishna Sundar, Md, MD | Internal Medicine | Provo, UT | $44,347 | $0 |
| Richard Schwab, Md, MD | Critical Care Medicine | Philadelphia, PA | $36,452 | $0 |
| Joseph Ojile, M.d, M.D | Pulmonary Disease | Saint Louis, MO | $26,088 | $0 |
| Thomas Gross, Md, MD | Internal Medicine | Iowa City, IA | $21,500 | $0 |
| Virend Somers, M.d, M.D | Cardiovascular Disease | Rochester, MN | $16,059 | $0 |
| Unknown Provider | — | — | $15,700 | $0 |
| Dr. David Whellan, M.d, M.D | Internal Medicine | Philadelphia, PA | $15,451 | $0 |
| Ms. Namratha Reddy, M.d, M.D | Internal Medicine | Memphis, TN | $12,500 | $0 |
| Abraham Malkin, M.d, M.D | Family Medicine | Los Angeles, CA | $11,490 | $0 |
| Dr. Sreelatha Naik, Md, MD | Critical Care Medicine | Danville, PA | $10,103 | $0 |
| Dr. David Schwartz, D.d.s Ltd, D.D.S LTD | General Practice | Skokie, IL | $9,542 | $0 |
| Wesley Fleming, Md, MD | Sleep Medicine | Irvine, CA | $8,150 | $0 |
| Dalane Kitzman, Md, MD | Cardiovascular Disease | Winston Salem, NC | $6,601 | $0 |
| Junaid Malik, Md, MD | Critical Care Medicine | Orlando, FL | $6,430 | $0 |
| Douglas Kirsch, Md, MD | Neurology | Charlotte, NC | $5,182 | $0 |
Top Products
- ApneaLink $650,827
- AirSense $533,604
Associated Products (14)
Payment Categories
- Food & Beverage $148,448
- Consulting $568,430
- Travel & Lodging $2,364
- Research $2.4M
- Royalties $87,428
About Resmed Corp
Resmed Corp has made $3.7M in payments to 4,091 healthcare providers, recorded across 7,400 transactions in the CMS Open Payments database. In 2024, the company paid $164,642. The top product by payment volume is ApneaLink ($650,827).
Payments were distributed across 110 medical specialties. The top specialty by payment amount is Sleep Medicine ($425,506 to 273 doctors).
Payment categories include: Food & Beverage ($148,448), Consulting ($568,430), Research ($2.4M), Travel & Lodging ($2,364), Royalties ($87,428).
Resmed Corp is associated with 14 products in the CMS Open Payments database, including ApneaLink, AirSense, and AIRSENSE.